Suppr超能文献

老年早期非小细胞肺癌患者的手术治疗及效果:一项巢式病例对照研究。

Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study.

机构信息

Department of Thoracic Surgery, Haut Lévêque Hospital, University of Bordeaux, Bordeaux.

Department of Thoracic Surgery, Civil Hospital, University of Strasbourg, Strasbourg.

出版信息

Chest. 2011 Oct;140(4):874-880. doi: 10.1378/chest.10-2841. Epub 2011 Mar 24.

Abstract

BACKGROUND

The number of oncogeriatric patients with non-small cell lung cancer (NSCLC) is expected to increase in the next decades.

METHODS

We used the French Society of Thoracic and Cardiovascular Surgery database Epithor that includes information on > 140,000 procedures from 98 institutions. We prospectively collected data from January 2004 to December 2008 on 1,969 patients aged ≥ 70 years with NSCLC stage I or II and matched them with 1,969 control subjects aged < 70 years for sex, American Society of Anesthesia score, performance status, and FEV(1). Surgical treatment and postoperative outcomes were compared between the two age groups.

RESULTS

The absence of radical lymphadenectomy was more frequent in the older patients (14%, n = 269) than in the younger patients (9%, n = 170) (P < .0001). There was no significant difference in type of resection between older and younger patients, respectively (pneumonectomy, 8% [n = 164] vs 11% [n = 216]; lobectomy, 79% [n = 1,559] vs 77% [n = 1,521]; bilobectomy, 4% [n = 88] vs 5% [n = 97]; sublobar resection, 7% [n = 143] vs 6% [n = 118]; P = .08). Differences in number (P = .07) and severity (P = .69) of complications were not significant. Postoperative mortality was higher in elderly patients at every end point (30-day mortality, 3.6% [n = 70] vs 2.2% [n = 43] [P = .01]; 60-day mortality, 4.1% [n = 80] vs 2.4% [n = 47] [P = .003]; 90-day mortality, 4.7% [n = 93] vs 2.5% [n = 50] [P = .0002]).

CONCLUSIONS

Elderly patients with NSCLC should not be denied pulmonary resection on the basis of chronologic age alone. Among patients aged ≥ 70 years, 90-day mortality compared acceptably with mortality among younger matched patients. Additionally, the data show that for older patients, a 90-day mortality better represents their real mortality risk than 30- or 60-day figures. Our contemporary, multiinstitutional data importantly reveal that elderly patients, compared with their younger counterparts, do not have increased morbidity, incidence, or severity after pulmonary resection.

摘要

背景

预计未来几十年患有非小细胞肺癌(NSCLC)的老年肿瘤患者数量将会增加。

方法

我们使用了包含来自 98 家机构的超过 140,000 例手术信息的法国胸心血管外科学会数据库 Epithor。我们前瞻性地收集了 2004 年 1 月至 2008 年 12 月期间 1,969 名年龄≥70 岁患有 I 期或 II 期 NSCLC 的患者的数据,并将他们与 1,969 名年龄<70 岁的对照组患者进行匹配,匹配因素包括性别、美国麻醉师协会评分、体能状态和 FEV(1)。比较了两组患者的手术治疗和术后结果。

结果

老年患者(14%,n=269)中未进行根治性淋巴结清扫术的比例高于年轻患者(9%,n=170)(P<.0001)。老年患者与年轻患者的手术切除类型无显著差异(肺切除术,8%[n=164] vs 11%[n=216];肺叶切除术,79%[n=1,559] vs 77%[n=1,521];双肺叶切除术,4%[n=88] vs 5%[n=97];亚肺叶切除术,7%[n=143] vs 6%[n=118];P=0.08)。并发症的数量(P=0.07)和严重程度(P=0.69)差异无统计学意义。在每个时间点,老年患者的术后死亡率都更高(30 天死亡率,3.6%[n=70] vs 2.2%[n=43],P=0.01;60 天死亡率,4.1%[n=80] vs 2.4%[n=47],P=0.003;90 天死亡率,4.7%[n=93] vs 2.5%[n=50],P=0.0002)。

结论

不应该仅根据年龄来拒绝对患有 NSCLC 的老年患者进行肺切除术。在年龄≥70 岁的患者中,90 天死亡率与年轻匹配患者的死亡率相当。此外,数据表明,对于老年患者,90 天死亡率比 30 天或 60 天的死亡率更能代表他们的实际死亡风险。我们的当代多机构数据重要地表明,与年轻患者相比,老年患者在接受肺切除术后,发病率、发病率或严重程度并未增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验